The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $65.80

Today's change-0.20 -0.30%
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $65.80

Today's change-0.20 -0.30%
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$0.20

Bristol-Myers Squibb Co closed lower Friday, dropping (U.S.)$0.20 or 0.30% to (U.S.)$65.80. Over the last five days, shares have gained 0.69% and are currently 4.91% off of the 52-week high. Shares have outperformed the S&P 500 by 17.03% during the last year.

Key company metrics

  • Open(U.S.) $65.82
  • Previous close(U.S.) $66.00
  • High(U.S.) $66.12
  • Low(U.S.) $65.20
  • Bid / Ask-- / --
  • YTD % change+11.47%
  • Volume5,393,455
  • Average volume (10-day)6,754,566
  • Average volume (1-month)6,086,592
  • Average volume (3-month)6,224,436
  • 52-week range(U.S.) $46.30 to (U.S.) $69.20
  • Beta0.25
  • Trailing P/E54.77×
  • P/E 1 year forward38.02×
  • Forward PEG2.35×
  • Indicated annual dividend(U.S.) $1.48
  • Dividend yield2.25%
  • Trailing EPS(U.S.) $1.20
Updated April 24 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.78%

Based on its net profit margin of 12.78%, Bristol-Myers Squibb Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue4,2583,9213,8893,811
Total other revenue--------
Total revenue4,2583,9213,8893,811
Gross profit3,3232,9502,9372,888
Total cost of revenue935971952923
Total operating expense4,3183,2103,4493,090
Selling / general / administrative1,3641,2001,1381,120
Research & development1,189918958898
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)877192538207
Other operating expenses, total-47-71-137-58
Operating income-60711440721
Interest income (expense), net non-operating-53-50-46-54
Gain (loss) on sale of assets-3315-7259
Other--------
Income before tax-601,008448985
Income after tax27732334936
Income tax, total-8727611449
Net income13721333937
Total adjustments to net income--------
Net income before extra. items13721333937
Minority interest-14-11-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items13721333937
Inc. avail. to common incl. extra. items13721333937
Diluted net income13721333937
Dilution adjustment--------
Diluted weighted average shares1,6761,6701,6691,666
Diluted EPS excluding extraordinary itemsvalue per share0.010.430.200.56
Dividends per sharevalue per share0.370.360.360.36
Diluted normalized EPSvalue per share0.350.350.580.60